International Ivermectin for COVID-19 Summit
Covid Summit webinar (May 23 2021)
See also: Previous Conference on Ivermectin (27 April 2021)
- Hosted by: TrialSiteNews
- Brought to you by Bird-Group
Introduction – Dr. Martin Gill (2:00)
Welcome – Daniel O’Connor (5:37)
Ivermectin use in Zimbabwe – Dr. Jackie Stone (9:20)
Introduction to Dr. Sabine Hazan (22:50)
Early to treat, early to cure – Dr. Sabine Hazan (26:10)
Introduction to Dr. David Scheim (36:45)
Ivermectin for COVID-19 treatment in Peru – Dr. David Scheim (37:40)
Introduction to Dr. Jennifer Hibberd (50:00)
World data – Dr. Jennifer Hibberd (51:00)
Introduction to Dr. Lucy Kerr (1:03:00)
Ivermectin as a prophylaxis and treatment – Dr. Lucy Kerr (1:05:22)
Introduction to Dr. Kylie M. Wagstaff (1:17:30)
In-vitro investigations of Ivermectin – Dr. Kylie M. Wagstaff (1:18:30)
Introduction to Dr. Tess Lawrie (1:34:25)
Sharing evidence on Ivermectin – Dr. Tess Lawrie (1:47:52)
Questions to the panel (1:48:20)
Closing keynote – Dr. Colleen Aldous
Key points of the talks: (01)
Ivermectin use in Zimbabwe – Dr. Jackie Stone
- Introduction to Dr. Jackie Stone
- Ivermectin use in Zimbabwe – Dr. Jackie Stone
- Hit hard, hit early, hit with combination therapy
- Almost tenfold reduction in mortality
- No further deaths in their hospital after adding Ivermectin to treatment protocol
- Improvement in oxygen saturation and circulation within 12 hours
- 95% of patients who need to go to hospital are managed at home
- Lockdown not effective in bringing numbers down
- Immediate drop in COVID deaths once Ivermectin became widely available
Early to treat, early to cure – Dr. Sabine Hazan
- Introduction to Dr. Sabine Hazan (Introduced by Prof. Thomas Barody – Australia)
- Outpatient Treatment of Severely COVID-Infected patients with Combination Therapy – Dr. Sabine Hazan
- Conducted the first placebo controlled clinical trials on Ivermectin
- Several cases of high risk patients on the verge of hospitalisation improving within hours after Ivermectin
- Over a hundred patients with oxygen saturation between 73% and 90% recovered
- The two patients that refused Ivermectin passed away
- The importance of combination therapy
Ivermectin for COVID-19 treatment in Peru – Dr. David Scheim
- Introduction to Dr. David Scheim
- Ivermectin for COVID-19 treatment in Peru – Dr. David Scheim
- 14-fold reduction in nationwide excess deaths
- 13-fold increase in deaths after Ivermectin use restricted
- Excess deaths by Ivermectin distribution: maximal: -86%, medium: -70%, minimal: -25%
- Sharp drops 1-11 days after Ivermectin distribution in states with maximal Ivermectin distribution, except 2 states
- Confounding effects, including lockdown effects were ruled out
- Study in hamsters reduced severity of symptoms by two-thirds with low doses of Ivermectin
- Study in mice with related virus cut viral load by 50%
- On 20 randomized controlled trials (RCT), pooled mortality showed 78% reduction in mortality
- On the RCT with the highest dose of Ivermectin, there was a 92% reduction in mortality
- A single low dose of Ivermectin yielded 50% reduction in symptoms
- Explanation on the biological mechanism of Ivermectin
World data – Dr. Jennifer Hibberd
- Introduction to Dr. Jennifer Hibberd
- World data – Dr. Jennifer Hibberd
- India – Data detailing how and why the outbreak spread in India
- India – New variants of concern detected where AstraZeneca vaccinations implemented
- India – Cases peaked a week after the Ivermectin protocol was implemented
- India – Sharp drops in states where Ivermectin protocol was implemented
- India – In states where Ivermectin was withdrawn from the protocol, cases continued to sharply rise
- Peru – Sharp drop after Ivermectin, and sharp rise after Ivermectin limited
- Mexico – In Mexico city trial shows 76% reduction in hospitalization
- Mexico – Results in more than 200,000 patients showed 73% reduction in severe symptoms
- Mexico – Implemented nationwide, 18 consecutive weeks of case reductions
- Mexico – Cases are now at lowest level since the pandemic began
- Mexico – Excess deaths follow the same pattern as the cases
- Mexico – Recent data shows that Mexico has COVID-19 under control and Ivermectin was the main driving force
Ivermectin as a prophylaxis and treatment – Dr. Lucy Kerr
- Introduction to Dr. Lucy Kerr
- Ivermectin as a prophylaxis and treatment – Dr. Lucy Kerr
- Detail how SARS‑CoV‑2 infects the cells: ACE2 receptors, lungs, inflammatory storm, immune system
- Ivermectin blocks the virus from docking into the ACE-2 receptors
- Ivermectin prevents entry to the nucleus and replication
- Ivermectin inactivates hypertoxic proteins
- 52 proteins related to the virus are regulated and inactivated by Ivermectin
- Ivermectin has potent, broad spectrum antiviral properties
- Ivermectin has antiviral, antibacterial, anti-inflammatory and immunity modulation properties
- Ivermectin is beneficial in all phases of the disease
- Prophylactic protocols for COVID-19
- Ivermectin is safe and cheap. Safety has been proven over billions of doses, no significant side effects
- Vaccines targeting the spike protein may introduce mutations, where Ivermectin does not
- Vaccines safety is still unknown
- 54% fewer cases, 72% fewer deaths 30 days after introduction of Ivermectin
- The low vaccination rates can not explain the reduction in cases/deaths
In-vitro investigations of Ivermectin as an anti-viral agent – Dr. Kylie M. Wagstaff
- Introduction to Dr. Kylie M. Wagstaff
- In-vitro investigations of Ivermectin – Dr. Kylie M. Wagstaff
- Ivermectin has anti-viral activity in-vitro against a range of viruses
- Effective in-vitro against dozens of viruses, e.g. SARS‑CoV‑2, West Nile Virus, Zika, Dengue
- 48 hours after Ivermectin there was no substantial viral RNA in-vitro
- Why the high in-vitro dosage on monkey kidney cells isn’t applicable in clinical use
- The likely mechanism of how Ivermectin works
- Ivermectin has a prophylactic potential
- Smaller repeated doses seems to be more effective than a single larger dose
Sharing evidence on Ivermectin – Dr. Tess Lawrie
- Introduction to Dr. Tess Lawrie
- Sharing evidence on Ivermectin – Dr. Tess Lawrie
- The role of researchers and biomedical journals
- On 2015, the WHO along with its stakeholders agreed on norms regarding data sharing in health emergencies
- These norms were not followed during the current pandemic
- By January 2021, there were 15 RCTs showing positive results from Ivermectin from low and middle income countries.
- There was systemic denigration of the quality of the studies
- Systemic hindrances to publication
- Systemic disinformation and censorship from big pharma and big tech
- Ivermectin has evidence at every level of the evidence pyramid
- Meta-analyses which are the top of the evidence pyramid, show 62% reduction in deaths
- Meta-analysis shows 67% reductions, 90% reduction in death used early in mild/moderate disease with high certainty
- Honduras – data shows a big drop in the case fatality rate weeks after Ivermectin treatment started
- Honduras – when cases rised in June, Ivermectin was delivered to the sick and their contacts. Rates have remained low since
- Mexico City – 200,000 participants were dispensed with medical kits. 52%-72% less hospitalization.
- Authorities that have approved experimental treatments without safety data.
- The same authorities rejected safe and effective medicines such as Ivermectin
- Ivermectin is a WHO essential medicine. Over 3.7 billions doses have been given over three decades.
- Ivermectin has orders of magnitude less deaths and adverse events compared to Remdesivir and the vaccines.
- The pharma companies were one of the few who gained from the pandemic, almost everyone else lost.
- The leading media companies agreed to promote the global vaccine rollout. This led to media silence on early treatments.
- Big tech has censored and spread disinformation about doctors who presented evidence of early treatment
Closing keynote – Dr. Colleen Aldous
- Closing keynote – Dr. Colleen Aldous)
- Global health authorities were always behind the curve – human to human transmission, asymptomatic transmission, airborne spread, etc.
- These delays increased the scale of the pandemic and cost countless lives
- Global and national bodies are slow to review and accept evidence
- The dominant medical paradigms are ill suited to pandemics
- There is more than enough compelling evidence
- The right to health and life is denied for everyone
- We need to combat the pandemic in every way. Vaccines on their own aren’t enough
- Many countries are working past the current recommendations
- Ivermectin is safe, effective, low cost, and easily distributed
- Ivermectin brings hope
Site Notifications/Chat:
- Telegram Post Updates @JourneyToABetterLife (channel)
- Telegram Chatroom @JourneyBetterLifeCHAT (say hi / share info)
- Gettr Post Updates @chesaus (like fakebook)
Videos:
References